Cell Reprogramming Could Make Tumors More Responsive to Immunotherapy

Cell reprogramming could make tumors more responsive to immunotherapy

In a new international study led by Lund University in Sweden, researchers have uncovered how reprogrammed cancer cells can help orchestrate the immune system's attack on tumors. Experiments in mice revealed how immune cells are recruited and organized within tumors to mount an immune response. The findings could pave the way for more effective immunotherapy and, ultimately, help more patients benefit from the treatment.

Reprogramming cancer cells to improve immunotherapy

Findings could pave the way for more effective immunotherapy and, ultimately, help more patients benefit from the treatment